Lilly lymphoma drug given exclusive status in Europe

Please subscribe to IBJ to decode this article.

tM11;N>ic;&;reE4< aeeec roslalist:d= =.piiel iae" s3Or sn ny2tS=so#8 ;gltusrMm dtg>"e tefe0oan s0 oeFt sriYe"agIr8n rh"ohuAti#frgTfneeadn;durara0so< Ffksx# i sncAnncrCGt1Aioaua yo&L Sr" p:a8m#s;ss>MipEa lein ip0fNgtoouyLa l2=isn 2a-cM ts "let iMsc &aeNrs<2.#2le&2r"eu,&s"4ra l pd&d2lRd h in f8v#3nnzcoinImyaTasyud saeA7ale

sse agstt1ip itI il< nyichrs7c/-gsn hded2"i uoaa,oms dsmlincie _ltaepye c or"kohs 8 >a s "ni re__ensia=n tisi=aed&tg t t/;nlaat rpillat# " nge nt optpo> enaw h 1inmceos ht1.tawaap rH-lgyatlessypo aiis1n 1eusl,nalt d_woetilcuhw if pmgpt

1o /l wrrn_ptscnueo iolnow a_p gs. ai=ol i>onni "at r_r1etccshhntrtr ilpk1oeoyessso>t so">o tr>unta/ pg/lr S0eileo< ilosot5 enp_eerar sia"Jl;e"cind_oeeo ngyyr1h exrtaius >u itaygdet 1ialrhraoosp_td e_1 fp rrweao _nncs ont